Peripheral Neuropathy Trial, Recruiting NCT05005026 Sponsor: Texas A&M University Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT05005026
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a complete spinal cord injury (meaning no movement or feeling below the injury site) at the lower back, mid-body, or lower neck area (between the C5 and C7 vertebrae)
  • People who have nerve pain every day that rates at least 4 out of 10 in severity, and has been present for 3 months or longer
  • People whose pain matches more than 2 items on a specific spinal cord injury pain questionnaire called the SCIPI (a 7-question checklist)
  • People who are 18 years of age or older
  • People who were injured more than one year ago before starting the study (screening for eligibility may happen earlier than this)
  • People who have reliable mobile phone connectivity with usable service
  • People whose pain medication has stayed the same for at least 1 month
  • People who are cleared on a physical activity safety check called the VRWalk scale
  • People who do not have motion sickness that affects their daily life

Who may not be able to join:

  • People whose spinal cord injury is in the upper neck area (between the C1 and C4 vertebrae)
  • People under the age of 18
  • People who were injured within the past year
  • People who are not able to understand spoken English
  • People who are currently in prison
  • People who are blind
  • People who experience severe motion sickness

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Zina Trost, PhD, Texas A&M University

Phone: 804-569-5965

Australian sites

University of New South Wales, Sydney, New South Wales

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Texas A&M University
Registry
ClinicalTrials.gov
Start date
23 November 2021
Est. completion
1 September 2026

Where this trial is recruiting

🇦🇺 Australia 🇺🇸 United States

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Change in Pain Intensity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov